James J. Ferguson III

Insider Reports History

Location
Bedminster, NJ
Signature
/s/ Matthew K. Szot, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James J. Ferguson III:

Company Role Class Num Shares Value Price $ Report Date Ownership
Matinas BioPharma Holdings, Inc. Chief Medical Officer Stock Option (right to Buy) 1,200,000 15 Dec 2023 Direct
Cadrenal Therapeutics, Inc. Chief Medical Officer Stock Options 60,000 05 Feb 2025 Direct

Insider Reports Filed by James J. Ferguson III

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CVKD Cadrenal Therapeutics, Inc. 05 Feb 2025 1 $0 4 Chief Medical Officer 06 Feb 2025, 16:51
CVKD Cadrenal Therapeutics, Inc. 05 Feb 2025 0 $0 3 Chief Medical Officer 06 Feb 2025, 16:50
MTNB Matinas BioPharma Holdings, Inc. 15 Dec 2023 1 $0 4 Chief Medical Officer 15 Dec 2023, 21:46
MTNB Matinas BioPharma Holdings, Inc. 20 Dec 2022 1 $0 4 Chief Medical Officer 22 Dec 2022, 10:17
MTNB Matinas BioPharma Holdings, Inc. 14 Dec 2021 1 $0 4 Chief Medical Officer 15 Dec 2021, 20:18